Harrison Parent '22
Harrison Parent ’22 of Belmont, NH, is studying Biochemistry and Molecular/Cellular Biology at COLSA. He recently presented his research at the 2022 UNH Undergraduate Research Conference.
Harrison Parent: Targeting BCL6 in Ovarian Cancer.
Harrison: I identified new drugs to assess the transcription factor BCL6 as a new protein target to treat metastatic ovarian cancer.
Harrison: Metastatic ovarian cancer, which is one of the most common and deadly gynecological malignancies in the U.S.
Harrison: I found that some newly identified drugs have shown promise in reducing ovarian cancer survival, as well as metastatic ability. This suggests that BCL6 may be utilized in targeted therapies to treat metastatic ovarian cancer in the future.
Harrison: It really allowed me to better understand the nuances of my own research and to improve my teaching and speaking abilities when discussing complicated topics with others less familiar in the subject area.
Harrison: I worked under the guidance of Dr. Sarah Walker of UNH's Molecular, Cellular, and Biomedical Sciences program. While the project and data are my own, I was also assisted throughout my research by both graduate and undergraduate members of the lab. Additionally, Center of Integrated Biomedical and Bioengineering Research-funded instruments were crucial to my research; without them, I would not have been able to obtain the data that I did.